Release Date: 29/03/23 16:39 Summary: RMS: Ramelius and Breaker copy of Bidders Statement Price Sensitive: No Download Document 3.52MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%